Myasthenia gravis:

Indications for: MYTELASE

Myasthenia gravis.

Adult Dosage:

Individualize. Usual range: 5–25mg 3 or 4 times daily. Increase gradually at intervals of 1–2 days. Some patients may require 50–75mg per dose. Increasing dosage above 200mg daily requires supervision by clinician aware of signs and treatment of overdose.

Children Dosage:

Not established.

MYTELASE Contraindications:

Concomitant atropine, mecamylamine, or any other ganglionic blocking agents.

MYTELASE Warnings/Precautions:

Monitor closely; narrow margin between first appearance of side effects and serious toxic effects. Asthma. Parkinson's disease. Mechanical intestinal or urinary obstruction. Bradycardia. Cardiac conduction disorders. Elderly. Pregnancy. Nursing mothers: not recommended.

MYTELASE Classification:

Cholinesterase inhibitor.

MYTELASE Interactions:

See Contraindications.

Adverse Reactions:

Overdosage (eg, excessive salivation, abdominal cramps, diarrhea, miosis, urinary urgency, sweating, nausea, increase in bronchial and lacrymal secretions, vomiting, muscle cramps, fasciculation of voluntary muscles, generalized malaise, anxiety, vertigo).

How Supplied: